Clinical trial / 2020
Supplementation with 6 g/day of oat beta-glucan improved glycemic control and reduced glycemic variability in adolescents with type 1 diabetes.
Thirty adolescents with type 1 diabetes completed three 1-week phases: Phase I with a standard diet, followed by Phase II adding oat flakes with 3 g/day beta-glucan, and Phase III adding oat flakes with 6 g/day beta-glucan. Maximal, mean, daytime, and night blood glucose levels were lowest at Phase III, while minimal blood glucose was highest at Phase III (p < 0.05). Premeal, postmeal, and peak blood glucose values were lowest at Phase III for breakfast, lunch, and overall, with delayed peak times (p < 0.05). Phase III also significantly reduced glycemic variability metrics including SD, CV, LBGI, and CONGA compared to Phase I or II (p < 0.05), while durations in hypoglycemia, euglycemia, and hyperglycemia did not differ significantly between phases.
- Study type
- Three-phase sequential intervention study
- Who was studied
- 30 adolescents with type 1 diabetes mellitus
- What was measured
- Glycemic control and glycemic variability parameters measured via continuous glucose monitoring
THE PAPER
The effect of beta-glucan supplementation on glycemic control and variability in adolescents with type 1 diabetes mellitus.
Bozbulut R, Şanlıer N, Döğer E, Bideci A, Çamurdan O, Cinaz P. Diabetes Res Clin Pract, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.